Consultation on Specialised Services clinical commissioning policies and service specifications

Overview

NHS England has today (2nd June 2017) launched a 30 day public consultation on a clinical commissioning policy for Hypofractionated external beam radiotherapy in the treatment of localised prostate cancer.  There has already been extensive engagement on this policy, it has been developed with the support and input of lead clinicians and patient and public representatives.

This approach has helped ensure that the views of key stakeholders have informed and influenced the development of this policy to date. We now wish to test it further with wider groups of stakeholders.

Related documents

Clinical Commissioning Policies

Hypofractionated external beam radiotherapy in the treatment of localised prostate cancer:

• Hypofractionated external beam radiotherapy in the treatment of localised prostate cancer Policy Proposition
• Impact Assessment Report
• Clinical Panel Report
• Stakeholder Engagement Report
• Evidence Review
• CPAG Summary Report